Postmenopausal bone mineral density in relation to soy isoflavone- metabolizing phenotypes

Maturitas

Volumn 53, Issue 3, 2006, Pages 315-324

  Frankenfeld, Cara L ^a,b   McTiernan, Anne ^a,b   Thomas, Wendy K ^a   LaCroix, Kristin ^a   McVarish, Lynda ^a   Holt, Victoria L ^a,b   Schwartz, Stephen M ^a,b   Lampe, Johanna W ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Bone mineral density; Daidzein; Equol; Hormones; Intestinal microflora; O Desmethylangolensin; Soy

Indexed keywords

DAIDZEIN; EQUOL; ESTRADIOL; ESTRONE; ISOFLAVONE; ISOFLAVONOID; O DESMETHYLANGOLENSIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DEMOGRAPHY; DRUG URINE LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; EXPLORATORY RESEARCH; FEMALE; HUMAN; INTESTINE FLORA; MAJOR CLINICAL STUDY; METABOLITE; PHENOTYPE; POSTMENOPAUSE; SOYBEAN; SPINE; URINALYSIS; URINARY EXCRETION;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; HUMANS; INTESTINES; ISOFLAVONES; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PHENOTYPE; PHYTOESTROGENS; POSTMENOPAUSE; SOYBEAN PROTEINS;

BACTERIA (MICROORGANISMS); GLYCINE MAX;

EID: 31544447433     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.05.016     Document Type: Article

References (32)

1. J.E. Compston Sex steroids and bone Physiol Rev 81 2001 419 447
2. P. Järvenpää, T. Kosunen, and T. Fotsis In vitro metabolism of estrogens by isolated intestinal micro-organisms and by human faecal microflora J Steroid Biochem 13 1980 345 349
3. K. Reinli, and G. Block Phytoestrogen content of foods-a compendium of literature values Nutr Cancer 26 1996 123 148
4. C. Atkinson, S. Berman, and O. Humbert In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production J Nutr 134 2004 596 599
5. Y.-C. Chang, and M.G. Nair Metabolism of daidzein and genistein by intestinal bacteria J Nat Prod 58 1995 1892 1896
6. E. Bowey, H. Adlercreutz, and I. Rowland Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats Food Chem Toxicol 41 2003 631 636
7. G.E. Kelly, G.E. Joannou, and A.Y. Reeder The variable metabolic response to dietary isoflavones in humans Proc Soc Exp Biol Med 208 1995 40 43
8. Y. Arai, M. Uehara, and Y. Sato Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake J Epidemiol 10 2000 127 135
9. J.W. Lampe, S.C. Karr, and A.M. Hutchins Urinary equol excretion with a soy challenge: influence of habitual diet Proc Soc Exp Biol Med 217 1998 335 339
10. A.M. Hutchins, J.L. Slavin, and J.W. Lampe Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products J Am Diet Assoc 95 1995 545 551
11. H. Akaza, N. Miyanaga, and N. Takashima Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration Jpn J Clin Oncol 32 2002 296 300
12. C.L. Frankenfeld, A. McTiernan, and E.J. Aiello Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women Cancer Epidemiol Biomarkers Prev 13 2004 1156 1162
13. H. Akaza, N. Miyanaga, and N. Takashima Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents Jpn J Clin Oncol 34 2004 86 89
14. A.M. Duncan, B.E. Merz-Demlow, and X. Xu Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer Cancer Epidemiol Biomarkers Prev 9 2000 581 586
15. A. McTiernan, C.M. Ulrich, and D. Yancey The physical activity for total health (PATH) study: rationale and design Med Sci Sports Exerc 31 1999 1307 1312
16. C.L. Frankenfeld, C. Atkinson, and W.K. Thomas Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes Exp Biol Med (Maywood) 229 2004 902 913
17. C.L. Frankenfeld, A. McTiernan, and S.S. Tworoger Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes J Steroid Biochem Mol Biol 88 2004 399 408
18. H.L. Bradlow, D.W. Sepkovic, and T. Klug Application of an improved ELISA assay to the analysis of urinary estrogen metabolites Steroids 63 1998 406 413
19. S. Heinonen, K. Wähälä, and H. Adlercreutz Identification of isoflavone metabolites dihydrodaidzein, dihydrogenistein, 6′-OH-O-dma, and cis-4-OH-equol in human urine by gas chromatography-mass spectroscopy using authentic reference compounds Anal Biochem 274 1999 211 219
20. K.D. Setchell, N.M. Brown, and E. Lydeking-Olsen The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones J Nutr 132 2002 3577 3584
21. C. Slemenda, C. Longcope, and M. Peacock Sex steroids, bone mass, and bone loss: a prospective study of pre-, peri-, and postmenopausal women J Clin Invest 97 1996 14 21
22. T.V. Nguyen, J.R. Center, and J.A. Eisman Association between breast cancer and bone mineral density: the Dubbo osteoporosis epidemiology study Maturitas 36 2000 27 34
23. S.R. Cummings, J.L. Kelsey, and M.C. Nevitt Epidemiology of osteoporosis and osteoporotic fractures Epidemiol Rev 7 1985 178 208
24. A.S. Turner, J.M. Maillet, and C. Mallinckrodt Bone mineral density of the skull in premenopausal women Calcif Tissue Int Aug 61 1997 110 113
25. E. Lydeking-Olsen, J.E. Beck-Jensen, and K.D. Setchell Soymilk or progesterone for prevention of bone loss-a 2 year randomized, placebo-controlled trial Eur J Nutr 43 2004 246 257
26. C.L. Frankenfeld, R.E. Patterson, and N.K. Horner Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women Am J Clin Nutr 77 2003 674 680
27. P. Horn-Ross, M. Lee, and E.M. John Sources of phytoestrogen exposure among non-Asian women in California, USA Cancer Causes Control 11 2000 299 302
28. M.J.J. de Kleijn, Y.T. van der Schouw, and P.W.F. Wilson Intake of dietary phytoestrogens is low in postmenopausal women in the United States: The Framingham Study J Nutr 131 2001 1826 1832
29. E. Schmitt, W. Dekant, and H. Stopper Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues Toxicol In Vitro 15 2001 433 439
30. L.M. Morimoto, E. White, and Z. Chen Obesity, body size, and risk of postmenopausal breast cancer: the Women's health initiative (United States) Cancer Causes Control 13 2002 741 751
31. C. Atkinson, C.L. Frankenfeld, and J.W. Lampe Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health Exp Biol Med (Maywood) 230 2005 155 170
32. G.E. Kelly, C. Nelson, and M.A. Waring Metabolites of dietary (soya) isoflavones in human urine Clin Chim Acta 223 1993 9 22